Abilify Off-Label Marketing Case Settled For $4M
The U.S. subsidiary of Japanese pharmaceutical company Otsuka Pharmaceutical Co. Ltd. has agreed to pay $4 million to settle off-label marketing allegations brought by the U.S. Department of Justice....To view the full article, register now.
Already a subscriber? Click here to view full article